TDP-43 frontotemporal lobar degeneration and autoimmune disease

Background The aetiology and pathogenesis of non-genetic forms of frontotemporal dementia (FTD) is unknown and even with the genetic forms of FTD, pathogenesis remains elusive. Given the association between systemic inflammation and other neurodegenerative processes, links between autoimmunity and FTD need to be explored. Objective To describe the prevalence of systemic autoimmune disease in semantic variant primary progressive aphasia (svPPA), a clinical cohort, and in progranulin (PGRN) mutation carriers compared with neurologically healthy normal controls (NC) and Alzheimer's disease (AD) as dementia controls. Design Case control. Setting Academic medical centres. Participants 129 svPPA, 39 PGRN, 186 NC and 158 AD patients underwent chart review for autoimmune conditions. A large subset of svPPA, PGRN and NC cohorts underwent serum analysis for tumour necrosis factor α (TNF-α) levels. Outcome measures χ2 Comparison of autoimmune prevalence and follow-up logistic regression. Results There was a significantly increased risk of autoimmune disorders clustered around inflammatory arthritides, cutaneous disorders and gastrointestinal conditions in the svPPA and PGRN cohorts. Elevated TNF-α levels were observed in svPPA and PGRN compared with NC. Conclusions svPPA and PGRN are associated with increased prevalence of specific and related autoimmune diseases compared with NC and AD. These findings suggest a unique pattern of systemic inflammation in svPPA and PGRN and open new research avenues for understanding and treating disorders associated with underlying transactive response DNA-binding protein 43 aggregation.

[1]  M. Pfreundschuh,et al.  Progranulin antibodies in autoimmune diseases. , 2013, Journal of autoimmunity.

[2]  L. Criswell,et al.  Emerging patterns of genetic overlap across autoimmune disorders , 2012, Genome Medicine.

[3]  Paul Thompson,et al.  Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia , 2012, Genome Medicine.

[4]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[5]  J. Trojanowski,et al.  A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.

[6]  Zhinan Yin,et al.  The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice , 2011, Science.

[7]  P. Kwok,et al.  Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases , 2011, Genes and Immunity.

[8]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[9]  John Q. Trojanowski,et al.  TAR DNA-binding protein 43 in neurodegenerative disease , 2010, Nature Reviews Neurology.

[10]  Sergio E Baranzini,et al.  The genetics of autoimmune diseases: a networked perspective. , 2009, Current opinion in immunology.

[11]  Atul J. Butte,et al.  Autoimmune Disease Classification by Inverse Association with SNP Alleles , 2009, PLoS genetics.

[12]  J. Olsen,et al.  Autoimmune disease and risk for Parkinson disease , 2009, Neurology.

[13]  I. Mackay,et al.  Clustering and commonalities among autoimmune diseases. , 2009, Journal of autoimmunity.

[14]  Karina D. Torralba,et al.  Sarcoidosis and the rheumatologist , 2009, Current opinion in rheumatology.

[15]  K. Heilman,et al.  Steroid treatment of primary progressive aphasia. , 2008, Archives of neurology.

[16]  S. Gabriel,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.

[17]  I. Palamaras,et al.  Lifetime prevalence distribution of chronic discoid lupus erythematosus , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  David Mann,et al.  Frontotemporal lobar degeneration: clinical and pathological relationships , 2007, Acta Neuropathologica.

[19]  Patrick L. McGeer,et al.  NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies , 2007, Neurobiology of Aging.

[20]  M. Mesulam,et al.  Vasectomy in Men With Primary Progressive Aphasia , 2006, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[21]  L. Melton,et al.  The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota , 2006, Gut.

[22]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[23]  J. Neuhaus,et al.  Comparison of family histories in FTLD subtypes and related tauopathies , 2005, Neurology.

[24]  D. Margolis,et al.  Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. , 2005, Archives of dermatology.

[25]  Animesh A Sinha,et al.  The role of T cells in cutaneous autoimmune disease , 2005, Autoimmunity.

[26]  K. Blennow,et al.  Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  M. Spyropoulou,et al.  Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. , 2004, Arthritis and rheumatism.

[28]  C. V. van Duijn,et al.  Medical and environmental risk factors for sporadic frontotemporal dementia: a retrospective case–control study , 2003, Journal of neurology, neurosurgery, and psychiatry.

[29]  R. Hirsch,et al.  Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. , 2003, Arthritis and rheumatism.

[30]  J. Flier,et al.  Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation , 2001, The Journal of pathology.

[31]  S. Pillemer,et al.  Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. , 2001, Mayo Clinic proceedings.

[32]  J. Michel,et al.  Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study , 2001, The Journal of pathology.

[33]  K. D. Fine,et al.  High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome , 2000, American Journal of Gastroenterology.

[34]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[35]  M. Albert,et al.  Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. , 1994, Archives of neurology.

[36]  N. Bagchi,et al.  Thyroid dysfunction in adults over age 55 years. A study in an urban US community. , 1990, Archives of internal medicine.

[37]  W. Castelli,et al.  The aging thyroid. Thyroid deficiency in the Framingham Study. , 1985, Archives of internal medicine.

[38]  J. Hodges,et al.  Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. , 2010, Brain : a journal of neurology.

[39]  Atlanta,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. , 2008, Arthritis and rheumatism.

[40]  C. Kreibich,et al.  Lichen sclerosus , 2005, Archiv für Dermatologie und Syphilis.

[41]  Fernando Gomollón Celiac sprue. , 2002, The New England journal of medicine.

[42]  K. Thomsen,et al.  Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. , 1977, Archives of dermatology.